“Funds will be used to accelerate regulatory activities, clinical and non-clinical development, and manufacture of drug toadvance ATH434 following recent release of its positive Phase 2 results in MSA. Funds will also be used to commence abusiness development process for potential partnering and to continue research and discovery of novel compounds totreat major indications such as Parkinson’s disease.”
Love this
” Funds will also be used to commence a business development process for a potential partnering “
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $33.14K | 3.314M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 12737751 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 483545 | 5 |
View Market Depth
| Last trade - 10.01am 30/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |